Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2793 - 2800 of 12062 results

Federal Jury Concludes Cryptocurrency Products NOT Securities
November 4, 2021| Blog| Viewpoint

Webinar Recording: H-1B Cap Planning
November 4, 2021| Webinar| Viewpoint

Mintz Adds ITC Pro From Adduci Mastriani
November 3, 2021| News

What’s New in 5G - November 2021
November 3, 2021| Blog| Viewpoint

NYSDOL Issues Guidance Regarding Employee Use of Cannabis
November 3, 2021| Blog| Viewpoint

Importance of a Firm Brand: Passle Podcast CMO Series
November 3, 2021| Podcast| Viewpoint

Mintz Life Sciences Deal Activity (July– September 2021)
November 1, 2021| Article| Viewpoint

Briefings on HIPAA: Inside the 21st Century ONC Cures Act
November 1, 2021| News
News & Press Releases
Mintz Advises PHLUR on Acquisition by TSG Consumer
July 29, 2025
Mintz advised PHLUR, a modern fragrance brand recognized for its emotion-led storytelling and accessible positioning, in its acquisition by TSG Consumer, a leading private equity firm specializing in consumer brands.
Mintz Attorneys Named to Los Angeles Business Journal’s 2025 “Leaders of Influence: Litigators & Trial Attorneys” List
July 28, 2025
Mintz Member Esteban Moralesand Special Counsel Nada Shamonki has been recognized by Los Angeles Business Journal in its 2025 “Leaders of Influence: Litigators & Trial Attorneys” list which recognizes lawyers who “go to the proverbial mat to fight for their clients,” according to the publication.
Is Biopharma M&A In a Holding Pattern or a ‘New Normal’
July 23, 2025
Life Sciences International Chair Cheryl Reicin recently joined the Scrip M&A Podcast to share insights on the evolving landscape of biopharmaceutical mergers and acquisitions. In the episode, Cheryl highlights an uptick in pre-M&A activity, as major pharmaceutical companies increasingly leverage license and option agreements to strengthen their pipelines and product portfolios while positioning themselves for potential future acquisitions.
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
